Company News

Medherant appoints new CEO John Burt will replace Current CEO, Nigel Davis, who will stay on as Chief Business Officer Connect 2 Cleanrooms appoints new MD and CEO Michael Wright will succeed founding MD Joe Govier who has moved to the CEO role Ex-FDA Commissioner joins Pfizer Scott Gottlieb will also be a part of the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board Newcomer Quell Therapeutics appoints Iain McGill as CEO The company was founded in March 2019, in a partnership between prominent experts from King's College London, University College London, and Hannover Medical School Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics In his new role Ahiska will spearhead the commercialisation of the group’s EpiSwitch technology platform Domain Therapeutics adds Sylvie Ryckebusch to Board Ryckebusch joins Domain from Merck Serono Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach Caddy-Leach will take on the role of Business Development Manager to support growing US presence MG America appoints Janice Wortham as Regional Sales Manager Wortham will cover the Processing division covering some on the most important pharma stronghold in the US ReViral appoints Alex Sapir as new CEO Sapir will be based at North Carolina’s Research Triangle Park alongside the company’s new CMO, Seth Hetherington Uhlmann Packaging Systems has new US Regional Sales Manager Markus Leuprecht will take over leading the Southwestern US and Texas Lyndra Therapeutics has new CEO Dr Patricia Hurter will begin her new post on 3 September TraceLink appoints four new Board Members New appointments include prominent supply chain industry leaders and former industry analysts; Roddy Martin, John Bermudez, Kevin Young and Steve Collins Ulrich Platte is new CFO of eTheRNA immunotherapies Platte will start at the mRNA immunotherapy company on 3 June Idifarma announces new Director of Operations Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals Immodulon appoints new CSO Effective immediately Thomas Kleen will take on the role within the senior management team Dr William F Feehery is new Certara CEO Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company

Trending Articles

  1. Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
  2. Chiesi appoints David Khougazian as Group chief executive officer David Khougazian to lead the next phase of innovation-driven growth
  3. Gerresheimer names new Chairman of the Supervisory Board This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
  4. Virginie Cavalli appointed Chief Executive Officer of Seppic Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026
  5. CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all